Departamento
Neurociencias
Publicaciones (32) Publicaciones en las que ha participado algún/a investigador/a
2012
-
Adjustment disorders in primary care: Prevalence, recognition and use of services
British Journal of Psychiatry, Vol. 201, Núm. 2, pp. 137-142
-
Alternativas comunitarias a la hospitalización de agudos para pacientes psiquiátricos graves
Actas Espanolas de Psiquiatria, Vol. 40, Núm. 6, pp. 323-332
-
Analgesic antidepressants promote the responsiveness of locus coeruleus neurons to noxious stimulation: Implications for neuropathic pain
Pain, Vol. 153, Núm. 7, pp. 1438-1449
-
Antioxidant defense system and family environment in adolescents with family history of psychosis
BMC Psychiatry, Vol. 12
-
Budgetary impact analysis of buprenorphine-naloxone combination (suboxone®) in Spain
Health Economics Review, Vol. 2, Núm. 1, pp. 1-9
-
Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes
Schizophrenia Research, Vol. 137, Núm. 1-3, pp. 66-72
-
Comparison of the antinociceptive effects of ibuprofen arginate and ibuprofen in rat models of inflammatory and neuropathic pain
Life Sciences, Vol. 90, Núm. 1-2, pp. 13-20
-
Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study
Schizophrenia Research, Vol. 137, Núm. 1-3, pp. 58-65
-
Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression
Anesthesiology, Vol. 117, Núm. 3, pp. 613-625
-
EVITAL: A preliminary taxonomy and electronic toolkit of health-related habits and lifestyle
The Scientific World Journal, Vol. 2012
-
Efectos asociados al policonsumo de drogas en fiestas rave
Health and addictions: salud y drogas, Vol. 12, Núm. 1, pp. 37-59
-
El deseo y el poder: problemas del discurso de la medicina basada en la evidencia aplicado a salud mental
Revista de la Asociación Española de Neuropsiquiatría, Vol. 32, Núm. 114, pp. 305-320
-
Elucidating the mechanism of action of pregabalin: α 2δ as a therapeutic target in Anxiety
CNS Drugs, Vol. 26, Núm. 8, pp. 637-648
-
Family burden related to clinical and functional variables of people with intellectual disability with and without a mental disorder
Research in Developmental Disabilities, Vol. 33, Núm. 3, pp. 796-803
-
Identification and location of hot and cold spots of treated prevalence of depression in Catalonia (Spain)
International Journal of Health Geographics, Vol. 11
-
La narcolepsia
MoleQla: revista de Ciencias de la Universidad Pablo de Olavide, Núm. 6, pp. 79-80
-
Life satisfaction in persons with Intellectual Disabilities
Research in Developmental Disabilities, Vol. 33, Núm. 4, pp. 1103-1109
-
Medida de la eficiencia técnica de programas de tratamiento con opiáceos: utilidad del modelo Data Envelopment Analysis (DEA)
Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías, Vol. 14, Núm. 3, pp. 79-88
-
Person-centred medicine and mental health
Epidemiology and Psychiatric Sciences, Vol. 21, Núm. 2, pp. 131-137
-
Preclinical discovery of duloxetine for the treatment of depression
Expert Opinion on Drug Discovery, Vol. 7, Núm. 8, pp. 745-755